PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18160611-3	2008	A 20-fold increase in the release of TFPI after phospholipase C treatment of HUVECs was demonstrated, confirming that it is glycosylphosphatidylinositol-lipid (GPI) anchored.	GPI 1046	160-163	tissue factor pathway inhibitor	Homo sapiens	37-41	
18160611-4	2008	Sequential treatment of HUVECs with phospholipase C and heparin was performed, and a trend was observed where GPI-anchored TFPI levels were increased after 1 hour of pretreatment with heparin but were decreased after 24 hours.	GPI 1046	110-113	tissue factor pathway inhibitor	Homo sapiens	123-127	
18261960-6	2008	Studies of cultured endothelial cells and human placenta have demonstrated that TFPI associates with the cell surface through a glycosyl phosphatidyinositol (GPI)-anchor in a manner that is not dependent on GAGs or altered by heparin.	GPI 1046	158-161	tissue factor pathway inhibitor	Homo sapiens	80-84